Cargando…
Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
OBJECTIVE: To assess changes in anticoagulation and fibrinolytic systems between biliary and hyperlipidaemic acute pancreatitis (AP). METHODS: Patients with biliary or hyperlipidaemic AP were enrolled. Demographic and clinical data were collected, and antithrombin III (ATIII), protein C, protein S,...
Autores principales: | Yang, Ning, Hao, Jianyu, Zhang, Donglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536593/ https://www.ncbi.nlm.nih.gov/pubmed/28222624 http://dx.doi.org/10.1177/0300060516677929 |
Ejemplares similares
-
Alteration of Antithrombin III and D-dimer Levels in Clinically Localized Prostate Cancer
por: Hong, Sung Kyu, et al.
Publicado: (2010) -
Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005) -
Serum levels of thyroid hormones and thyroid stimulating hormone in patients with biliogenic and hyperlipidaemic acute pancreatitis: Difference and value in predicting disease severity
por: Yang, Ning, et al.
Publicado: (2016) -
Management of the Hyperlipidaemic Patient
por: Lewis, Barry
Publicado: (1988) -
Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia
por: Joshi, Deepti, et al.
Publicado: (2021)